{"id":385,"date":"2018-01-02T21:41:55","date_gmt":"2018-01-02T20:41:55","guid":{"rendered":"https:\/\/10storks.com\/?p=385"},"modified":"2018-01-02T21:41:55","modified_gmt":"2018-01-02T20:41:55","slug":"cbr-cord-blood-registry","status":"publish","type":"post","link":"https:\/\/imedicalsociety.org\/cbr-cord-blood-registry\/","title":{"rendered":"CBR Cord Blood Registry"},"content":{"rendered":"
CBR Systems Incorporated (Cord Blood Registry) is a biotechnology company in the field of stem cells<\/a> banking with more than 20 years of experience in this specific area.\u00a0 Along with the service of banking stem cells<\/a>, Cord Blood Registry funds clinical trials focused on the research and development of new therapeutic modalities that include stem cells application<\/a>, what is also the case for ViaCord<\/a>, Maze,<\/a> FamilyCord<\/a> and others.<\/a> This organization, as a cord blood registry, strives to find a cure for severe conditions that cannot be appropriately managed today, despite the many cord blood uses<\/a> available, and aims to find possibilities and solutions for families and their members who suffer from potentially life-threatening diseases.<\/p>\n This company, Cord Blood Registry is one of the many companies reviewed in this article<\/a>, in comparison to some of its competitors, such as StemCyte.<\/a><\/p>\n Cord Blood Registry stores approximately a half of the overall number of stem cell units in the country, being one of the most important cord blood banks in the United States<\/a>.<\/p>\n